Skip to main content
Log in

Bone mineral density in patients with Parkinson’s Disease

  • Short Communication
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background and aims: This study assesses bone mineral density (BMD) in the lumbar spine, proximal femur and hand, and examines the relationship between BMD and disease duration, Hoehn and Yahr staging in Turkish elderly patients with Parkinson’s disease (PD). Design: Twenty-four PD patients and 31 age- and sex-matched controls took part in the study. The BMD in the lumbar spine (L2-L4), femoral neck, Ward’s triangle, trochanter and bilateral hands were evaluated by dual X-ray absorptiometry (DXA). Results: There was no significant difference in right hand BMD (rHBMD), L2-L4 spinal BMD, and right proximal femur BMD between patients and controls. However, in female patients hand BMD and right femoral neck BMD were significantly lower than in female controls (p<0.05). Male patients had no significant difference in BMD measurements in any sites compared with controls. Patients’ Hoehn and Yahr index and disease duration were negatively correlated with BMD in all sites except L2-L4. Conclusions: We emphasize the increased risk for osteoporosis in elderly female patients with PD, which is more prominent in proximal femur and hand measurements. Elderly female patients should be carefully examined and screened for osteoporosis to prevent bone loss and associated disability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Aita JF. Why patients with Parkinson’s disease fall. JAMA 1982; 247: 515–6.

    Article  PubMed  CAS  Google Scholar 

  2. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med 1991; 324: 1326–31.

    Article  PubMed  CAS  Google Scholar 

  3. Koller WC, Glatt S, Vetere-Overfield B, Hassanein R. Falls and Parkinson’s disease. Clin Neuropharmacol 1989; 12: 98–105.

    Article  PubMed  CAS  Google Scholar 

  4. Biering-Sorensen F, Bohr HH, Schaadt OP. Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury. Eur J Clin Invest 1990; 20: 330–5.

    Article  PubMed  CAS  Google Scholar 

  5. Chantraine A, Nusgens B, Lapiere CM. Bone remodeling during the development of osteoporosis in paraplegia. Calcif Tissue Int 1986; 38: 323–7.

    Article  PubMed  CAS  Google Scholar 

  6. Sato Y, Manabe S, Kuno H, Oizumi K. Amelioration of osteopenia and hypovitaminosis D by 1 alpha-hydroxyvitamin D3 in elderly patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999; 66: 64–8.

    Article  PubMed  CAS  Google Scholar 

  7. Ishizaki F, Harada T, Katayama S, Abe H, Nakamura S. Relationship between osteopenia and clinical characteristics of Parkinson’s disease. Mov Disord 1993; 8: 507–11.

    Article  PubMed  CAS  Google Scholar 

  8. Ishizaki F, Harada T, Katayama S, Abe H, Nakamura S. Bone changes in Parkinson’s disease. No To Shinkei 1993; 45: 719–24.

    PubMed  CAS  Google Scholar 

  9. Revilla M, de la Sierra G, Aguado F, Varela L, Jimenez-Jimenez FJ, Rico H. Bone mass in Parkinson’s disease: a study with three methods. Calcif Tissue Int 1996; 58: 311–5.

    PubMed  CAS  Google Scholar 

  10. Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A. Bone mineral density in hip-fracture patients with Parkinson’s disease: a case-control study. Arch Phys Med Rehabil 2006; 87: 1459–62.

    Article  PubMed  Google Scholar 

  11. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Abnormal bone and calcium metabolism in immobilized Parkinson’s disease patients Mov Disord 2005; 20: 1598–603.

    Google Scholar 

  12. Ardicoglu O, Ozgocmen S, Kamanli A, Pekkutucu I. Relationship between bone mineral density and radiologic scores of hands in rheumatoid arthritis. J Clin Densitom 2001; 4: 263–9.

    Article  PubMed  CAS  Google Scholar 

  13. Kao CH, Chen CC, Wang SJ, Chia LG, Yeh SH. Bone mineral density in patients with Parkinson’s disease measured by dual photon absorptiometry. Nucl Med Commun 1994; 15: 173–7.

    Article  PubMed  CAS  Google Scholar 

  14. Rico H, Vazquez A, Cabranes JA, et al. Long-term influence of levodopa on bone mass and growth hormone in postmenopausal women with Parkinson’s disease. Clin Neuropharmacol 1987; 10: 87–91.

    Article  PubMed  CAS  Google Scholar 

  15. Turc JD, Pages M, Paulles JM, et al. Bone changes in Parkinson’s disease. Neurology 1993; 43: A236.

    Google Scholar 

  16. Sato Y, Kaji M, Tsuru T, Oizumi K. Risk factors for hip fracture among elderly patients with Parkinson’s disease. J Neurol Sci 2001; 182: 89–93.

    Article  PubMed  CAS  Google Scholar 

  17. Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S. The effects of estrogen replacement on early Parkinson’s disease. Neurology 1999; 52: 1417–21.

    Article  PubMed  CAS  Google Scholar 

  18. Birdwood G. Normal bone and its development. In: Understanding osteoporosis and its Treatment. New York: Parthenon Publishing, 1996: 17–36.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ayhan Kamanli MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kamanli, A., Ardicoglu, O., Ozgocmen, S. et al. Bone mineral density in patients with Parkinson’s Disease. Aging Clin Exp Res 20, 277–279 (2008). https://doi.org/10.1007/BF03324774

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03324774

Keywords

Navigation